Literature DB >> 1321034

Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding.

N A Lokker1, M R Mark, E A Luis, G L Bennett, K A Robbins, J B Baker, P J Godowski.   

Abstract

Hepatocyte growth factor (HGF) is a potent mitogen for parenchymal liver, epithelial and endothelial cells. Structurally, it has similarities to kringle-containing serine proteases, although it does not possess proteolytic activity. A structure-activity relationship study of human HGF was performed by functional analysis of HGF substitution and deletion variants. Analysis of HGF variants was accomplished by defining their ability to induce DNA synthesis on hepatocytes in primary culture and to compete with wild-type HGF for binding to a soluble form of the HGF receptor. Three groups of variants were made: (i) substitutions at the cleavage site, (ii) substitutions within the protease-like domain and (iii) deletions of the beta-chain and/or kringle domains. Our results show that: (i) single-chain HGF is a zymogen-like promitogen in that cleavage into a two-chain form is required for biological activity, however, the single chain form of HGF still retains substantial receptor binding capacity; (ii) certain mutations in the protease-like domain result in variants that are completely defective for mitogenic activity, yet exhibit apparent receptor binding affinities similar to wild-type HGF (Kd approximately 50-70 pM); and (iii) a variant containing the N-terminal 272 residues of mature HGF showed only a 4-fold increase in Kd when compared with wild-type HGF indicating that a primary receptor binding determinant is located within this sequence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321034      PMCID: PMC556725          DOI: 10.1002/j.1460-2075.1992.tb05315.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

1.  The hormonal control of gluconeogenesis by regulation of mitochondrial pyruvate carboxylation in isolated rat liver cells.

Authors:  J C Garrison; R C Haynes
Journal:  J Biol Chem       Date:  1975-04-25       Impact factor: 5.157

2.  A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor.

Authors:  J S Rubin; A M Chan; D P Bottaro; W H Burgess; W G Taylor; A C Cech; D W Hirschfield; J Wong; T Miki; P W Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

3.  Identification of a competitive HGF antagonist encoded by an alternative transcript.

Authors:  A M Chan; J S Rubin; D P Bottaro; D W Hirschfield; M Chedid; S A Aaronson
Journal:  Science       Date:  1991-11-29       Impact factor: 47.728

4.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

5.  Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing.

Authors:  G A Rodrigues; M A Naujokas; M Park
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

6.  Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth.

Authors:  K Matsumoto; H Tajima; T Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1991-04-15       Impact factor: 3.575

7.  An alternatively processed mRNA generated from human hepatocyte growth factor gene.

Authors:  K Miyazawa; A Kitamura; D Naka; N Kitamura
Journal:  Eur J Biochem       Date:  1991-04-10

8.  Purification and characterization of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats.

Authors:  O Asami; I Ihara; N Shimidzu; S Shimizu; Y Tomita; A Ichihara; T Nakamura
Journal:  J Biochem       Date:  1991-01       Impact factor: 3.387

9.  Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration.

Authors:  P M Lindroos; R Zarnegar; G K Michalopoulos
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

10.  Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factor.

Authors:  Y Yoshiyama; N Arakaki; D Naka; K Takahashi; S Hirono; J Kondo; H Nakayama; E Gohda; N Kitamura; H Tsubouchi
Journal:  Biochem Biophys Res Commun       Date:  1991-03-15       Impact factor: 3.575

View more
  73 in total

Review 1.  Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy?

Authors:  W M Wong; R J Playford; N A Wright
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

2.  The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat.

Authors:  P Pediaditakis; J C Lopez-Talavera; B Petersen; S P Monga; G K Michalopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

Review 3.  Targeting the HGF/Met signaling pathway in cancer therapy.

Authors:  Fabiola Cecchi; Danie C Rabe; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

4.  An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.

Authors:  Kyle E Landgraf; Micah Steffek; Clifford Quan; Jeffrey Tom; Christine Yu; Lydia Santell; Henry R Maun; Charles Eigenbrot; Robert A Lazarus
Journal:  Nat Chem Biol       Date:  2014-05-25       Impact factor: 15.040

5.  Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli.

Authors:  S J Stahl; P T Wingfield; J D Kaufman; L K Pannell; V Cioce; H Sakata; W G Taylor; J S Rubin; D P Bottaro
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

6.  A human recombinant IL-7/HGFβ hybrid cytokine enhances antitumor immunity in mice.

Authors:  Feng Han; Rong Hu; Min Su; Yanni Yu; Hua Yang; Laijun Lai
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

7.  Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride.

Authors:  J J Maher
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium.

Authors:  A Nusrat; C A Parkos; A E Bacarra; P J Godowski; C Delp-Archer; E M Rosen; J L Madara
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 9.  Targeting the Met signaling pathway in renal cancer.

Authors:  Alessio Giubellino; W Marston Linehan; Donald P Bottaro
Journal:  Expert Rev Anticancer Ther       Date:  2009-06       Impact factor: 4.512

10.  Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.

Authors:  W M Mars; R Zarnegar; G K Michalopoulos
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.